KIMS Ltd to host institutional investor meet on September 10

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Krishna Institute of Medical Sciences Limited hosts investor meet on September 10, 2026
  • Event begins at 2:30 pm at KIMS Mahadevpura facility
  • Hosted by Emkay Global with group and one-on-one sessions
  • Discussions limited to publicly available information only
powered bylight_fuzz_icon
50329424

*this image is generated using AI for illustrative purposes only.

Krishna Institute of Medical Sciences Limited will host an institutional investor meeting on September 10, 2026. The event aims to facilitate interaction between company officials and analysts.

The meeting is scheduled for Thursday, September 10, 2026, starting at 2:30 pm. It will be hosted by Emkay Global and held at the KIMS Mahadevpura facility.

Meeting Details

The company disclosed the schedule under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The format includes both group and one-on-one sessions conducted in person.

Date / Time Event Type / Mode Venue
September 10, 2026, 2:30 pm Institutional Investor Meeting hosted by Emkay Global Group Meeting / One on One – In Person KIMS Mahadevpura

Disclosure Notes

Discussions during the meeting will rely solely on publicly available information. The company confirmed that no unpublished price-sensitive information will be shared. The schedule remains subject to change due to exigencies on the part of participants or the company.

Nagajyanthi J. R, Company Secretary and Compliance Officer, signed the disclosure on September 7, 2026.

Historical Stock Returns for Krishna Institute of Medical Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-0.25%+0.38%-5.66%+13.48%+0.60%0.0%

How might the strategic priorities discussed by KIMS management at this meeting influence their capital allocation for hospital expansions in 2027?

What specific operational metrics or growth targets is Emkay Global likely to probe regarding KIMS's post-pandemic recovery trajectory?

Could insights from this investor meeting signal any potential changes in dividend policy or share buyback plans for the upcoming fiscal year?

Krishna Institute of Medical Sciences
View Company Insights
View All News
like15
dislike

KIMS AGM voting results show strong support for all resolutions

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • All five resolutions at KIMS' 24th AGM passed with requisite majority
  • Financial statements for FY26 approved with 99.99% support
  • Ms. Dandamudi Anitha reappointed as director with 74.46% approval
  • Special resolutions for loans and guarantees secured 78.38% and 78.50% support respectively
  • Promoters voted unanimously in favour of all agenda items
powered bylight_fuzz_icon
49389157

*this image is generated using AI for illustrative purposes only.

Krishna Institute of Medical Sciences shareholders approved all five resolutions at its 24th Annual General Meeting held on August 27, 2026. The company released the final voting results and scrutinizer's report on August 30, 2026, confirming that each item passed with the requisite majority.

The meeting was conducted via video conferencing and other audio-visual means. Of the 97,610 shareholders on the record date, 421 members cast votes, representing approximately 84.9% of outstanding shares.

Meeting Proceedings

The AGM commenced at 4:00 pm and concluded at 6:00 pm. Seventy-one members attended through video conferencing or other audio-visual means. Dr. Bhaskara Rao Bollineni, Chairman and Managing Director, welcomed shareholders and introduced board members present at the meeting.

Ms. Nagajanthi J. R., Company Secretary and Compliance Officer, informed attendees that e-voting facilities were provided by MUFG Intime India Private Limited. M/s. IKR & Associates served as the scrutinizer for the voting process.

Resolutions Passed

Shareholders voted on the following items of business:

Resolution Type Votes in Favour Votes Against % in Favour
Adoption of financial statements for FY26 Ordinary 35,65,61,087 105 99.99997%
Reappointment of Ms. Dandamudi Anitha as director Ordinary 26,16,22,035 8,97,55,408 74.4561%
Ratification of cost auditor remuneration Ordinary 35,65,64,204 285 99.99992%
Approval for loans/guarantees under Section 185 Special 27,94,80,731 7,70,83,758 78.3815%
Approval of overall limits for loans/investments Special 27,99,17,476 7,66,46,793 78.5041%

Statutory auditor M/s. S.R. Batliboi & Associates LLP and secretarial auditor M/s. IKR & Associates attended the meeting virtually. The final voting results have been disseminated to stock exchanges and published on the company website.

Voting Analysis

Promoter and Promoter Group shareholders voted unanimously in favour of all resolutions. Public institutional shareholders showed significant dissent on the reappointment of Ms. Dandamudi Anitha, with 49.49% voting against the resolution. However, strong support from public non-institutional shareholders ensured the resolution passed with an overall 74.46% approval.

Similarly, the special resolutions regarding loans and guarantees faced opposition from public institutions, with approximately 41% voting against both items. Despite this, the resolutions secured over 78% support overall, driven by unanimous promoter backing and near-unanimous support from retail investors.

Historical Stock Returns for Krishna Institute of Medical Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
-0.25%+0.38%-5.66%+13.48%+0.60%0.0%

How might the significant dissent from public institutional shareholders regarding Ms. Dandamudi Anitha's reappointment impact the company's future corporate governance strategies?

What specific financial risks or opportunities are associated with the approved limits for loans and guarantees under Section 185, and how will they affect the company's balance sheet in FY27?

Given the high approval rate for financial statements, what key performance indicators should investors monitor to assess if the company meets its projected growth targets for the upcoming fiscal year?

Krishna Institute of Medical Sciences
View Company Insights
View All News
like18
dislike

More News on Krishna Institute of Medical Sciences

1 Year Returns:+0.60%